Daito Pharmaceutical Co (TSE:4577) Total Liabilities : 円25,308 Mil (As of Feb. 2024)

View and export this data going back to 2010. Start your Free Trial

What is Daito Pharmaceutical Co Total Liabilities?

Daito Pharmaceutical Co's Total Liabilities for the quarter that ended in Feb. 2024 was 円25,308 Mil.

Daito Pharmaceutical Co's quarterly Total Liabilities increased from Aug. 2023 (円20,185.00 Mil) to Nov. 2023 (円22,869.00 Mil) and increased from Nov. 2023 (円22,869.00 Mil) to Feb. 2024 (円25,308.00 Mil).

Daito Pharmaceutical Co's annual Total Liabilities increased from May. 2021 (円15,823.00 Mil) to May. 2022 (円17,268.00 Mil) and increased from May. 2022 (円17,268.00 Mil) to May. 2023 (円19,581.00 Mil).

Daito Pharmaceutical Co Total Liabilities Historical Data

The historical data trend for Daito Pharmaceutical Co's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Daito Pharmaceutical Co Total Liabilities Chart

Daito Pharmaceutical Co Annual Data

Trend

May14

May15

May16

May17

May18

May19

May20

May21

May22

May23

Total Liabilities

Get a 7-Day Free Trial

15,399.71

17,381.38

15,823.00

17,268.00

19,581.00

Daito Pharmaceutical Co Quarterly Data
	May19	Aug19	Nov19	Feb20	May20	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Feb23	May23	Aug23	Nov23	Feb24
Total Liabilities	Get a 7-Day Free Trial															18,752.00	19,581.00	20,185.00	22,869.00	25,308.00

Daito Pharmaceutical Co Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Daito Pharmaceutical Co's Total Liabilities for the fiscal year that ended in May. 2023 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	15428	+	(3445	+	201
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	507)
	=	19,581

Total Liabilities	=	Total Assets (A: May. 2023 )	-	Total Equity (A: May. 2023 )
	=	70552	-	50971
	=	19,581

Daito Pharmaceutical Co's Total Liabilities for the quarter that ended in Feb. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	18693	+	(5194	+	988
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	433)
	=	25,308

Total Liabilities	=	Total Assets (Q: Feb. 2024 )	-	Total Equity (Q: Feb. 2024 )
	=	77351	-	52043
	=	25,308

Daito Pharmaceutical Co Total Liabilities Related Terms

Thank you for viewing the detailed overview of Daito Pharmaceutical Co's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Daito Pharmaceutical Co (TSE:4577) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Daito Pharmaceutical Co Ltd (TSE:4577) » Definitions » Total Liabilities

Comparable Companies

Traded in Other Exchanges

N/A

Address

326 Yokamachi, Toyama, JPN, 939-8567

Website

http://www.daitonet.co.jp

Daito Pharmaceutical Co Ltd is engaged in the research and development of pharmaceutical products. The company also undertakes contract manufacturing.

Daito Pharmaceutical Co (TSE:4577) Headlines

No Headlines